344 related articles for article (PubMed ID: 10547389)
21. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
[TBL] [Abstract][Full Text] [Related]
22. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
Yamada KM; Araki M
J Cell Sci; 2001 Jul; 114(Pt 13):2375-82. PubMed ID: 11559746
[TBL] [Abstract][Full Text] [Related]
24. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function.
Miyamoto S; Akiyama SK; Yamada KM
Science; 1995 Feb; 267(5199):883-5. PubMed ID: 7846531
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells.
Maguire JE; Danahey KM; Burkly LC; van Seventer GA
J Exp Med; 1995 Dec; 182(6):2079-90. PubMed ID: 7500053
[TBL] [Abstract][Full Text] [Related]
26. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
Cantley LC; Neel BG
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4240-5. PubMed ID: 10200246
[TBL] [Abstract][Full Text] [Related]
27. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
28. CDX2 inhibits invasion and migration of gastric cancer cells by phosphatase and tensin homologue deleted from chromosome 10/Akt signaling pathway.
Liu YQ; Bai ZG; Ma XM; Zhang ZT
Chin Med J (Engl); 2015 Apr; 128(8):1065-71. PubMed ID: 25881601
[TBL] [Abstract][Full Text] [Related]
29. The Cold Spring Harbor Laboratory meeting on tyrosine phosphorylation and cell signaling. Cold Spring Harbor, NY, USA, May 12-16, 1999.
Roussel MF
Biochim Biophys Acta; 2000 Feb; 1470(1):R17-20. PubMed ID: 10656991
[No Abstract] [Full Text] [Related]
30. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion.
Zagzag D; Nomura M; Friedlander DR; Blanco CY; Gagner JP; Nomura N; Newcomb EW
J Cell Physiol; 2003 Aug; 196(2):394-402. PubMed ID: 12811834
[TBL] [Abstract][Full Text] [Related]
31. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression.
Rutka JT; Muller M; Hubbard SL; Forsdike J; Dirks PB; Jung S; Tsugu A; Ivanchuk S; Costello P; Mondal S; Ackerley C; Becker LE
J Neuropathol Exp Neurol; 1999 Feb; 58(2):198-209. PubMed ID: 10029102
[TBL] [Abstract][Full Text] [Related]
32. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
33. Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN.
Attwell S; Mills J; Troussard A; Wu C; Dedhar S
Mol Biol Cell; 2003 Dec; 14(12):4813-25. PubMed ID: 12960424
[TBL] [Abstract][Full Text] [Related]
34. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
[TBL] [Abstract][Full Text] [Related]
35. Signal transduction through integrins: a central role for focal adhesion kinase?
Richardson A; Parsons JT
Bioessays; 1995 Mar; 17(3):229-36. PubMed ID: 7748177
[TBL] [Abstract][Full Text] [Related]
36. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
[TBL] [Abstract][Full Text] [Related]
37. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion.
Chiarugi P; Pani G; Giannoni E; Taddei L; Colavitti R; Raugei G; Symons M; Borrello S; Galeotti T; Ramponi G
J Cell Biol; 2003 Jun; 161(5):933-44. PubMed ID: 12796479
[TBL] [Abstract][Full Text] [Related]
38. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
39. Integrin-mediated signaling in normal and malignant cells: a role of protein tyrosine kinases.
Malik RK; Parsons JT
Biochim Biophys Acta; 1996 Jun; 1287(2-3):73-6. PubMed ID: 8672530
[No Abstract] [Full Text] [Related]
40. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.
Miao H; Burnett E; Kinch M; Simon E; Wang B
Nat Cell Biol; 2000 Feb; 2(2):62-9. PubMed ID: 10655584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
